115 Cerebral insulin resistance may arise from the downregulation of insulin transport across the blood-brain barrier secondary to chronic peripheral hyperinsulinemia and systemic insulin resistance 116 as well as from the loss of neuronal membrane insulin receptors induced by soluble amyloid-beta (A) oligomers
In contrast, the mean relative risk reduction in studies involving individuals with T2D, where weight loss was between 2% and 5%, was 15%, as seen in the aforementioned trials (48, 57, 59, 71)
Exenatide once a week assisted more patients in reaching the majority of ADA-recommended therapeutic goals than treatment with sitagliptin, pioglitazone, or insulin glargine
( Epub ahead of print ) Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H et al (2020) American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1
